OOIR: Observatory of International Research

Papers

(The TQCC of Personalized Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
The role of circular RNAs in therapy resistance of patients with solid tumors	36
Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls	31
The evolution of personalized healthcare and the pivotal role of European regions in its implementation	30
Assessment of healthcare professionals’ knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt	29
Elevated expression of ASF1B correlates with poor prognosis in human lung adenocarcinoma	17
Increase inMEG3, MALAT1, NEAT1significantly predicts the clinical parameters in patients with rheumatoid arthritis	15
The United States 2020 Census data: implications for precision medicine and the research landscape	15
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection	14
Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research	12
Artificial intelligence in healthcare: a primer for medical education in radiomics	12
MiR-452-5p mediates the proliferation, migration and invasion of hepatocellular carcinoma cells via targeting COLEC10	11
Promoter region single nucleotide polymorphism of siglec-8 gene associates with susceptibility to allergic asthma	10
The frequency of majorCYP2C19genetic polymorphisms in women of Asian, Native Hawaiian and Pacific Islander subgroups	9
Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review	9
Clinical validity of a gene expression signature in diagnostically uncertain neoplasms	9
Engaging community stakeholders in research on best practices for clinical genomic sequencing	9
Recommendations to researchers for aiding in increasing American Indian representation in genetic research and personalized medicine	8
Toward precision health: applying artificial intelligence analytics to digital health biometric datasets	8
Clinician perspectives on communication and implementation challenges in precision oncology	8
Personalized medicine in Latin America	8
Intelligent health system for the investigation of consenting COVID-19 patients and precision medicine	8
Clinical significance and functions of miR-203a-3p/AVL9 axis in human non-small-cell lung cancer	8
miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with rs738409 polymorphism in PNPLA3	8
Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned	8
Public interest in whole genome sequencing and information needs: an online survey study	8

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology	7
Stem cells as therapeutic targets in colorectal cancer	7
CYP2D6 does not impact on breast cancer-free survival in Southeast Mexican patients under tamoxifen treatment	7
Predictive role of single nucleotide polymorphism (rs11614913) in the development of breast cancer in Pakistani population	7
LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial–mesenchymal transition in endometrial carcinoma	7
Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications	6
Clinical significance of serum miR-101-3p expression in patients with neonatal sepsis	6
Concentration and integrity indexes of urine cell-free DNA as promising biomarkers for early lung cancer diagnosis	6
Nudges and the meaningful adoption of digital health	6
The role of miR-101 in esophageal and gastric cancer	6
Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer	6
MiR-455-5p serves as a biomarker of atherosclerosis and inhibits vascular smooth muscle cell proliferation and migration	6
Mini-gut feelings: perspectives of people with cystic fibrosis on the ethics and governance of organoid biobanking	5
Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancer	5
Expanded carrier screening in Flanders (Belgium): an online survey on the perspectives of nonpregnant reproductive-aged women	5
The enduring importance of family health history in the era of genomic medicine and risk assessment	5
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine	5
Attitudes of Costa Rican individuals towards donation of personal genetic data for research	5
Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals	5
Nutrigenetics and nutrigenomics: ready for clinical use or still a way to go?	5
Alignment of health plan coverage policies for somatic multigene panel testing with clinical guidelines in select solid tumors	4
Defining the role of pharmacists in medication-related genetic counseling	4
Application of transcriptomics and proteomics in pulmonary arterial hypertension	4
Personalized therapy: can it tame the COVID-19 monster?	4
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites	4
Views on genomic research result delivery methods and informed consent: a review	4
Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk	4
PON1 polymorphisms can predict generalized anxiety and depressed mood in patients with multiple chemical sensitivity	4
Targeting molecular alterations in non-small-cell lung cancer: what's next?	4
Association study of genetic polymorphisms inGABRDwith treatment response and dose in methadone maintenance treatment	4
The integration of personalized medicine into health systems: progress and a path forward	4